BackArtivion Overview
Artivion Inc

Artivion Target Price

Analysts' average 12-month price target for Artivion is $35.

Get informed when a big investor buys or sells

+ Follow

Share Price

$20.21

Average Target Price

$35.0073.2% upside

4 analysts in the last 4 months

High: $40 | Low: $30

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-11-06Canaccord GenuityWilliam Plovanic$3048.4% upsideOpen
2026-10-20JefferiesMichael Sarcone$3153.4% upsideOpen
2026-08-18Canaccord GenuityWilliam Plovanic$4097.9% upsideOpen
2026-08-07Canaccord GenuityWilliam Plovanic$3993% upsideOpen
2026-06-16Canaccord GenuityWilliam Plovanic$3678.1% upsideOpen
2026-06-01Stifel NicolausJohn McAulay$45122.7% upsideOpen
2026-03-05Stifel NicolausJohn McAulay$55172.1% upsideOpen
2025-12-17Canaccord GenuityWilliam Plovanic$51152.4% upsideOpen
2025-11-07OppenheimerSuraj Kalia$50147.4% upsideOpen
2025-08-08NeedhamMike Matson$45122.7% upsideOpen
2024-10-23JMP SecuritiesDaniel Stauder$3363.3% upsideOpen
2024-08-09OppenheimerSuraj Kalia$3048.4% upsideOpen
2024-07-10Lake StreetFrank Takkinen$3048.4% upsideOpen
2024-07-02Loop Capital MarketsFrank Takkinen$3048.4% upsideOpen
2024-05-07NeedhamMike Matson$3048.4% upsideOpen

Artivion (AORT) FAQ

Artivion's target price stands at $35. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $35 for AORT implies 73.2% upside versus today's price ($20.21). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Artivion's target price evolved across reporting periods, while the comparison chart places AORT next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, target price is commonly used to spot outliers. Artivion's reading of $35 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.